 Fasting
"Fasting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abstaining from all food.
| Descriptor ID |
D005215
|
| MeSH Number(s) |
F01.145.407.400 G07.203.650.240.587 G07.203.650.353.400
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fasting".
Below are MeSH descriptors whose meaning is more specific than "Fasting".
This graph shows the total number of publications written about "Fasting" by people in this website by year, and whether "Fasting" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 3 | 3 | | 2000 | 1 | 5 | 6 | | 2001 | 0 | 3 | 3 | | 2002 | 2 | 1 | 3 | | 2003 | 0 | 4 | 4 | | 2004 | 1 | 4 | 5 | | 2005 | 1 | 6 | 7 | | 2006 | 5 | 1 | 6 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 1 | 4 | 5 | | 2010 | 3 | 0 | 3 | | 2011 | 1 | 7 | 8 | | 2012 | 3 | 6 | 9 | | 2013 | 1 | 12 | 13 | | 2014 | 3 | 5 | 8 | | 2015 | 2 | 8 | 10 | | 2016 | 4 | 7 | 11 | | 2017 | 1 | 4 | 5 | | 2018 | 2 | 6 | 8 | | 2019 | 6 | 9 | 15 | | 2020 | 6 | 7 | 13 | | 2021 | 1 | 3 | 4 | | 2022 | 4 | 6 | 10 | | 2023 | 1 | 3 | 4 | | 2024 | 2 | 2 | 4 | | 2025 | 4 | 2 | 6 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Fasting" by people in Profiles.
-
Liu JJ, Liu S, de Keizer J, Zheng H, Lee J, Javaugue V, Gurung RL, Ang K, Potier L, Nelson RG, Kestenbaum B, Bjornstad P, Lim SC, Hadjadj S, Saulnier PJ. Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes. Nephrol Dial Transplant. 2026 Jun 30; 41(7):1304-1312.
-
Farabi SS, Barbour LA, Dunn EZ, Ingram C, Lopez E, Hinojosa J, Phillips E, Hirsch N, Rolloff K, Pierce S, Friedman JE, Hernandez TL. Portable Home-Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease. Endocrinol Diabetes Metab. 2026 May; 9(3):e70237.
-
Breit MJ, Caldwell AE, Ostendorf DM, Pan Z, Creasy SA, Swanson B, Clark K, Hill EB, MacLean PS, Bessesen DH, Melanson EL, Catenacci VA. Effects of 4:3 Intermittent Fasting on Eating Behaviors and Appetite Hormones: A Secondary Analysis of a 12-Month Behavioral Weight Loss Intervention. Nutrients. 2025 Jul 21; 17(14).
-
Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Hurtado Andrade MD, Mendez CE, Kelley KD, Stewart E, Fernandez Robles CR, Chadha RM, Camilleri M, Mathur R, Umpierrez GE, Hepner DL. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025 Jul; 135(1):48-78.
-
van Baar MJB, Muskiet MHA, Scholtes RA, Touw DJ, Nieuwdorp M, Kramer MHH, Joles JA, Cherney DZI, Bjornstad P, Krebber MM, van Raalte DH. Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono- and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double-blind trial. Diabetes Obes Metab. 2025 Jul; 27(7):3943-3956.
-
Catenacci VA, Ostendorf DM, Pan Z, Kaizer LK, Creasy SA, Zaman A, Caldwell AE, Dahle J, Swanson B, Breit MJ, Bing K, Wayland LT, Panter SL, Scorsone JJ, Bessesen DH, MacLean P, Melanson EL. The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months : A Randomized Clinical Trial. Ann Intern Med. 2025 05; 178(5):634-644.
-
Sevilla-González M, Smith K, Wang N, Jensen AE, Litkowski EM, Kim H, DiCorpo DA, Hsu S, Cui J, Liu CT, Yu C, McNeil JJ, Lacaze P, Westerman KE, Chang KM, Tsao PS, Phillips LS, Goodarzi MO, Sladek R, Rotter JI, Dupuis J, Florez JC, Merino J, Meigs JB, Zhou JJ, Raghavan S, Udler MS, Manning AK. Heterogeneous effects of genetic variants and traits associated with fasting insulin on cardiometabolic outcomes. Nat Commun. 2025 Mar 15; 16(1):2569.
-
Oldenburg N, Mashek DG, Harnack L, Wang Q, Manoogian ENC, Evanoff N, Dengel DR, Taddese A, Yentzer BP, Lysne L, Wong A, Hanson M, Anderson JD, Alvear A, LaPage N, Ryder J, Varady K, Gao Z, Ryu S, Bolan PJ, Bergman B, Helgeson E, Panda S, Chow LS. Time-restricted eating, caloric reduction, and unrestricted eating effects on weight and metabolism: a randomized trial. Obesity (Silver Spring). 2025 Apr; 33(4):671-684.
-
Huneault HE, Lo JS, Bai S, He Z, McPhaul MJ, Bril F, Vos MB, Cree MG. Fasting intact insulin by mass spectrometry is associated with metabolic dysfunction-associated steatotic liver disease in youth. Hepatol Commun. 2024 12 01; 8(12).
-
Johnson SL, Murray G, Manoogian ENC, Mason L, Allen JD, Berk M, Panda S, Rajgopal NA, Gibson JC, Bower CD, Berle EF, Joyner K, Villanueva R, Michalak EE, Kriegsfeld LJ. A pre-post trial to examine biological mechanisms of the effects of time-restricted eating on symptoms and quality of life in bipolar disorder. BMC Psychiatry. 2024 10 21; 24(1):711.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|